The CancerLinQ® Community Is Built on the Strength of Millions
The information that populates the CancerLinQ database comes from millions of people with cancer. But our community also includes healthcare professionals in our participating practices who derive valuable insights toward the care of their patients, as well as our Conquer Cancer Foundation donors who make CancerLinQ possible. As members of the CancerLinQ community, we are all part of a special movement, one that will change the way we treat people with cancer for generations to come.
CancerLinQ is the convener of the cancer community.
CancerLinQ is much more than just a data platform. CancerLinQ is a community movement of committed, collaborative partners from across the entire healthcare ecosystem who are invested in improving the lives of millions of people around the world.
The power of partnership is of paramount importance to us. We are convening the entire cancer community and creating our coalition of support with all key people and partners, including patients, providers, payers, academia, industry, government, NGOs, advocacy groups, entrepreneurs, technology companies, our sister medical specialty societies, forward-thinking thought leaders, and innovative change agents.
By bringing together the best minds and most impassioned voices, together we declare our commitment to transcend boundaries, harness our collective strengths, accelerate advancement to solutions, and maximize the value of what we can offer to our patients.
Ultimately, CancerLinQ will help the cancer community make the right decisions for the right patients at the right time. We welcome you to join our coalition.
We’d like to introduce the CancerLinQ™ Certified EHR Program! EHRs that are certified as optimized for use with CancerLinQ™ are eligible for benefits such as special designation in communications, publications, and ASCO meetings. Contact Us for additional information.
CancerLinQ Discovery™ allows the oncology community to translate big data from CancerLinQ’s pool of de-identified patient data into real world insights to drive research that can improve the care of all cancer patients. It will derive these sets from the rapidly-growing CancerLinQ® database. CancerLinQ Discovery™ will begin accepting research proposals on October 1, 2017. If you have any questions before then, please contact Discovery@CancerLinQ.org.
The Conquer Cancer Foundation (CCF) was founded by the foremost cancer doctors of the American Society of Clinical Oncology (ASCO) to seek dramatic advances in the prevention, treatment, and cures of all types of cancer. With your help, CCF works to conquer this disease by funding breakthrough cancer research and sharing cutting-edge knowledge with patients and physicians worldwide, by improving the quality of and access to care, and by enhancing quality of life for all who are touched by cancer. Visit the Conquer Cancer Foundation of ASCO. CancerLinQ is funded in part through Conquer Cancer Foundation
Foundations, corporations, and individual donors have already expressed their confidence in our vision through financial support. Visit the Conquer Cancer Foundation of ASCO to see how you can join them.
Many thanks to Genentech:
Genentech a member of the Roche Group, is a world leader in biotechnology. Genentech commitment to improving cancer care inspired the organization’s generous support of CancerLinQ. They have supported the program because they see a responsibility to develop the best personalized treatment to improve patient care.